BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mussap M, Loddo C, Fanni C, Fanos V. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics. Expert Rev Clin Pharmacol 2020;13:115-34. [PMID: 31958027 DOI: 10.1080/17512433.2020.1713750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo W, Cao P, Wang X, Hu M, Feng Y. Medicinal Plants for the Treatment of Gastrointestinal Cancers From the Metabolomics Perspective. Front Pharmacol 2022;13:909755. [DOI: 10.3389/fphar.2022.909755] [Reference Citation Analysis]
2 Tee KB, Ibrahim L, Hashim NM, Saiman MZ, Zakaria ZH, Huri HZ. Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes. Pharmaceutics 2022;14:1268. [PMID: 35745841 DOI: 10.3390/pharmaceutics14061268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gandhi S, Chinnadurai V, Bhadra K, Gupta I, Kanwar RS. Urinary metabolic modulation in human participants residing in Siachen: a 1H NMR metabolomics approach. Sci Rep 2022;12:9070. [PMID: 35641596 DOI: 10.1038/s41598-022-13031-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Carlos Alarcon-Barrera J, Kostidis S, Ondo-Mendez A, Giera M. Recent advances in metabolomics analysis for early drug development. Drug Discov Today 2022:S1359-6446(22)00076-9. [PMID: 35218927 DOI: 10.1016/j.drudis.2022.02.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2022;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
6 Phapale P. Pharmaco‐metabolomics opportunities in drug development and clinical research. Analytical Science Advances 2021;2:611-6. [DOI: 10.1002/ansa.202000178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Naithani N, Sinha S, Misra P, Vasudevan B, Sahu R. Precision medicine: Concept and tools. Med J Armed Forces India 2021;77:249-57. [PMID: 34305276 DOI: 10.1016/j.mjafi.2021.06.021] [Reference Citation Analysis]
8 Mussap M, Noto A, Piras C, Atzori L, Fanos V. Slotting metabolomics into routine precision medicine. Expert Review of Precision Medicine and Drug Development 2021;6:173-87. [DOI: 10.1080/23808993.2021.1911639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]